M. Leslie, “T cells found in COVID-19 patients ‘bode well’ for long-term immunity“, Science, doi:10.1126/science.abc8120.
A. Grifoni, et al, “Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals“, Cell, 14th May 2020.
J. Braun, L. Loyal, et al, “Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors“, medRχiv (not peer-reviewed, with comments), 22 April 2020.
34% of non-CV19 patients in Germany already had the Coronavirus spike protein specific helper T-cells. Due most likely to infection with prior common cold coronaviruses. That number is close to the percentage of “asymptomatic cases” we are seeing.
34% of non-CV19 patients in Germany already had the Coronavirus spike protein specific helper T-cells. Due most likely to infection with prior common cold coronaviruses. That number is close to the percentage of “asymptomatic cases” we are seeing.
ecoquant
